Presentations from Previous LRIG Events See past presentations on the YouTube LRIG Channel
|
Presentations
| Selection | File type icon | File name | Description | Size | Revision | Time | User |
|---|
Meeting PDF Presentation| Selection | File type icon | File name | Description | Size | Revision | Time | User |
|---|---|---|---|---|---|---|---|
| Ċ | View Download |
9620k | v. 2 | Jan 14, 2019, 7:28 AM | Rodney Bednar | ||
| Ċ | View Download |
Application of Human iPSC-Derived Neurons for Phenotypic Screening and Disease Modeling | 13265k | v. 3 | Nov 18, 2014, 6:08 PM | Rodney Bednar | |
| Ċ | View Download |
Presentation 02/06: Automation of compound management at Schering-Plough Research Institute (SPRI) Marybeth Burton; Associate Director, Chemical Technologies Schering-Plough Research Institute | 648k | v. 3 | Nov 18, 2014, 5:58 PM | Rodney Bednar |
| Selection | File type icon | File name | Description | Size | Revision | Time | User |
|---|---|---|---|---|---|---|---|
| ć | View Download |
Presentation "About LRIG" at the LRIG Texas meeting on February 21, 2013 | 4576k | v. 3 | Nov 18, 2014, 5:54 PM | Rodney Bednar |
| Selection | File type icon | File name | Description | Size | Revision | Time | User |
|---|---|---|---|---|---|---|---|
| Ċ | View Download |
"Keynote Speaker" David Schultz “A Discovery Platform for Translation of Innovative Basic Science in Academia” | 455k | v. 2 | Jun 29, 2015, 2:36 PM | Rodney Bednar | |
| Ċ | View Download |
Steven LaBrenz “Adapting to Highly Randomized Experimental Designs in Formulation Development” | 164k | v. 2 | Jun 29, 2015, 2:40 PM | Rodney Bednar | |
| Ċ | View Download |
Daniel Trout "HTS Applications Supporting Large Molecule Drug Development” | 1632k | v. 2 | Jun 29, 2015, 3:03 PM | Rodney Bednar | |
| Ċ | View Download |
Bob Dunst "Automated Nanoliter-scale Immunoassays: Expanding Discovery Productivity for Bioanalysis" | 1641k | v. 2 | Jun 29, 2015, 3:03 PM | Rodney Bednar | |
| Ċ | View Download |
Malcolm Crook "Scheduling techniques for laboratory automation" | 412k | v. 2 | Jun 29, 2015, 3:04 PM | Rodney Bednar | |
| Ċ | View Download |
Dana Campbell “Artel presents newest system that measures volume within wells by pressure technology” | 456k | v. 2 | Jun 29, 2015, 3:04 PM | Rodney Bednar | |
| Ċ | View Download |
Stephen Kosteski "Complex Assays: Cells, Beads, Microbes and Mixtures Made Simple with the iQue® Screener platform from IntelliCyt" | 2535k | v. 2 | Jun 29, 2015, 3:05 PM | Rodney Bednar | |
| Ċ | View Download |
Todd Smith "Plate Washing and Media Change by Centrifugation: Overcoming limitations of aspiration based washers" | 1072k | v. 2 | Jun 29, 2015, 3:05 PM | Rodney Bednar | |
| Ċ | View Download |
Ali Safavi "Reduce Cost and Waste Through Innovation" | 1316k | v. 2 | Jun 29, 2015, 3:05 PM | Rodney Bednar | |
| Ċ | View Download |
757k | v. 2 | Oct 11, 2017, 9:08 AM | Rodney Bednar | ||
| Ċ | View Download |
2365k | v. 2 | Oct 11, 2017, 9:08 AM | Rodney Bednar | ||
| Ċ | View Download |
6223k | v. 2 | Oct 11, 2017, 9:08 AM | Rodney Bednar | ||
| Ċ | View Download |
6473k | v. 2 | Oct 11, 2017, 9:08 AM | Rodney Bednar | ||
| Ċ | View Download |
1820k | v. 2 | Oct 11, 2017, 9:08 AM | Rodney Bednar | ||
| Ċ | View Download |
973k | v. 2 | Oct 11, 2017, 9:08 AM | Rodney Bednar | ||
| Ċ | View Download |
903k | v. 2 | Oct 11, 2017, 9:08 AM | Rodney Bednar | ||
| Ċ | View Download |
3043k | v. 2 | Oct 11, 2017, 9:08 AM | Rodney Bednar |
| Selection | File type icon | File name | Description | Size | Revision | Time | User |
|---|---|---|---|---|---|---|---|
| Ċ | View Download |
"Social Networking for Scientists" by Christie Wicox | 10398k | v. 3 | Nov 18, 2014, 8:40 PM | Rodney Bednar |
| Selection | File type icon | File name | Description | Size | Revision | Time | User |
|---|---|---|---|---|---|---|---|
|
ċ
|
View |
Biologics pose unique challenges for nonclinical toxicology testing. Although the general principles of nonclinical toxicity testing are the same for biologics and small molecule drugs, additional factors to consider include species relevance, long half-life, the potential for immunogenicity, and the possibility of performing the FIH study in a patient population. Successful strategies for dealing with these issues will be discussed. | Nov 18, 2014, 6:03 PM | Rodney Bednar |